Telecare Provides Comparable Efficacy to Conventional Self-Monitored Blood Glucose in Patients with Type 2 Diabetes Titrating One Injection of Insulin Glulisine—the ELEONOR Study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We compared telecare and conventional self-monitored blood glucose (SMBG) programs for titrating the addition of one bolus injection of insulin glulisine in patients with type 2 diabetes uncontrolled on oral hypoglycemic agents for ≥3 months who were first titrated with basal insulin glargine. METHODS: This randomized, multicenter, parallel-group study included 241 patients (mean screening glycosylated hemoglobin [HbA(1c)], 8.8% [73 mmol/mol]). In the run-in phase, any antidiabetes medication, except for metformin, was discontinued. Metformin was then up-titrated to 2 g/day (1 g twice daily) until study completion. Following run-in, all patients started glargine for 8-16 weeks, targeting fasting plasma glucose (FPG) ≤5.6 mmol/L using conventional SMBG. Patients with FPG ≤7 mmol/L added a glulisine dose at the meal with the highest postprandial plasma glucose excursion, titrated to target 2-h postprandial plasma glucose level <7.8 mmol/L using telecare or SMBG for 24 weeks. Patients with FPG >7 mmol/L at week 16 were withdrawn from the study. RESULTS: After glargine titration, 224 patients achieved FPG ≤7 mmol/L, without any difference between telecare and SBMG groups (mean±SD, 6.2±0.8 vs. 6.0±0. 9 mmol/L, respectively). HbA(1c) levels were lower following titration and were similar for telecare and SMBG (7.9±0.9% vs. 7.8±0.9% [63 vs. 62 mmol/mol], respectively). Adding glulisine further reduced HbA(1c) in both groups (-0.7% vs. -0.7%); 45.2% and 54.8% (P=0.14), respectively, of patients achieved HbA(1c) ≤7.0% (≤53 mmol/mol). Weight change and hypoglycemia were similar between groups. CONCLUSIONS: Patients adding one dose of glulisine at the meal with the highest postprandial plasma glucose excursion to titrated basal glargine achieved comparable improvements in glycemic control irrespective of traditional or telecare blood glucose monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Three-year efficacy of complex insulin regimens in type 2 diabetes
Holman, R. R., Farmer, A. J., Davies, M. J., Levy, J. C., Darbyshire, J. L., Keenan, J. F., & Paul, S. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905479 · Cited by 667
Janka, H. U., Plewe, G., Riddle, M. C., Kliebe-Frisch, C., Schweitzer, M. A., & Yki-Järvinen, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.254 · Cited by 414 · cited 1×
“The Treating to Target in Type 2 Diabetes study(6) has shown that adding basal or prandial insulin regimens to OHAs is effective in improving glycemic control, more so than biphasic insulin; several other studies have also demonstrated the possibility of achieving good glycemic control with basal insulin.(7,8) Althoug…”
Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes
Kim, S.-I., & Kim, H.-S. (2008) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2007.07.006 · Cited by 180
Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control
Montori, V. M., Helgemoe, P. K., Guyatt, G. H., Dean, D. S., Leung, T. W., Smith, S. A., & Kudva, Y. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1088 · Cited by 169
Cho, J.-H., Lee, H.-C., Lim, D.-J., Kwon, H.-S., & Yoon, K.-H. (2009) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2008.080412 · Cited by 155
New technologies for chronic disease management and control: a systematic review
García-Lizana, F., & Sarría-Santamera, A. (2007) · Journal of Telemedicine and Telecare · doi:10.1258/135763307780096140 · Cited by 138
Research works printed but not linked: 15
- 10.1016/S0169-2607(02)00037-8 · DOI
- 10.1016/S0169-2607(02)00039-1 · DOI · Paper page
- 10.1111/j.1463-1326.2008.00980.x · DOI · Paper page
- 10.1111/j.1463-1326.2008.00967.x · DOI
- 10.1111/j.1463-1326.2008.00846.x · DOI · Paper page
- 10.1002/dmrr.733 · DOI
- 10.1111/j.1463-1326.2011.01459.x · DOI · Paper page
- 10.1089/dia.2008.0114 · DOI · Paper page
- 10.2337/diacare.26.11.3080 · DOI
- 10.2337/dc11-0900 · DOI
- 10.2337/dc07-2137 · DOI · Paper page
- 10.1016/j.diabres.2004.03.003 · DOI · Paper page
- 10.1016/j.clinthera.2008.11.001 · DOI · Paper page
- 10.1002/dmrr.989 · DOI
- 10.2147/VHRM.S10952 · DOI · Paper page
Cited by
Interactive telemedicine: effects on professional practice and health care outcomes
Flodgren, G., Rachas, A., Farmer, A. J., Inzitari, M., & Shepperd, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002098.pub2 · Cited by 806
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019) · Telemedicine and e-Health · doi:10.1089/tmj.2018.0128 · Cited by 239
Zhai, Y.-K., Zhu, W.-J., Cai, Y.-L., Sun, D.-X., & Zhao, J. (2014) · Medicine · doi:10.1097/md.0000000000000312 · Cited by 221
Su, D., Zhou, J., Kelley, M. S., Michaud, T. L., Siahpush, M., Kim, J., Wilson, F., Stimpson, J. P., & Pagán, J. A. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.019 · Cited by 164
Metadata
- Authors
- Prato, S. D., Nicolucci, A., Lovagnini-Scher, A. C., Turco, S., Leotta, S., & Vespasiani, G.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2012-02
- Volume
- 14
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1982616521
- Cited by
- 54
- References
- 7
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telecare Provides Comparable Efficacy to Conventional Self-Monitored Blood Glucose in Patients with Type 2 Diabetes Titrating One Injection of Insulin Glulisine—the ELEONOR Study. https://app.cochat.ai/papers/10.1089/dia.2011.0163
- The paper
- Prato, S. D., Nicolucci, A., Lovagnini-Scher, A. C., Turco, S., Leotta, S., & Vespasiani, G. (2012). Telecare Provides Comparable Efficacy to Conventional Self-Monitored Blood Glucose in Patients with Type 2 Diabetes Titrating One Injection of Insulin Glulisine—the ELEONOR Study. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2011.0163
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.